Document is current
Any future updates will be listed below
-
Authors
Solomon, Pierre https://orcid.org/0000-0001-7187-2664
Kaurani, Lalit https://orcid.org/0000-0002-2304-6111
Budde, Monika
Guiné, Jean-Baptiste
Krüger, Dennis Manfred https://orcid.org/0000-0003-1950-9547
Riquin, Kevin https://orcid.org/0000-0003-1774-0286
Pena, Tonatiuh https://orcid.org/0000-0002-9329-8912
Burkhardt, Susanne
Fourgeux, Cynthia https://orcid.org/0000-0002-3330-7530
Adorjan, Kristina
Heilbronner, Maria
Kalman, Janos L.
Kohshour, Mojtaba Oraki https://orcid.org/0000-0002-1357-2636
Papiol, Sergi https://orcid.org/0000-0001-9366-8728
Reich-Erkelenz, Daniela
Schaupp, Sabrina K.
Schulte, Eva C. https://orcid.org/0000-0003-3105-5672
Senner, Fanny
Vogl, Thomas
Anghelescu, Ion-George
Arolt, Volker https://orcid.org/0000-0002-2445-9778
Baune, Bernhardt T.
Dannlowski, Udo https://orcid.org/0000-0002-0623-3759
Dietrich, Detlef E.
Fallgatter, Andreas J.
Figge, Christian
Juckel, Georg
Konrad, Carsten
Reimer, Jens https://orcid.org/0009-0007-5406-5319
Reininghaus, Eva Z. https://orcid.org/0000-0001-5964-4087
Schmauß, Max
Spitzer, Carsten
Wiltfang, Jens https://orcid.org/0000-0003-1492-5330
Zimmermann, Jörg
Schütz, Anna-Lena
Sananbenesi, Farahnaz
Sauvaget, Anne
Falkai, Peter https://orcid.org/0000-0002-0284-2290
Schulze, Thomas G. https://orcid.org/0000-0001-6624-2975
Fischer, André
Heilbronner, Urs https://orcid.org/0000-0001-7135-762X
Poschmann, Jeremie https://orcid.org/0000-0002-9613-5297
- License Information
-
More Information
Article History
Received: 17 April 2024
Revised: 3 March 2025
Accepted: 4 April 2025
First Online: 23 April 2025
Change Date: 12 May 2025
Change Type: Update
Change Details: In this article ref. 40 and 41 was incorrect and should have been '<i>These authors contributed equally to this work and share first authorship</i>'.
Competing interests
: Two co-authors provide the following financial interest and personal relationships which may be considered as potential competing interests: JW, that organized the PsyCourse recruitment at the Göttingen university medical center, receives consulting fees from Immungenetics, Noselab, Roboscreen, is member of advisory boards of Abbott, Biogen, Boehringer Ingelheim, Lilly, MSD SHARP DOHME, Roche; received payment for lectures from Beeijing Yibai Science and Technology Ltd., Gloryren, Janssen Cilag, Pfizer, Med Update GmbH, Roche Pharma, Lilly and holds patents PCT/EP 2011 001724 and PCT/EP 2015 052945. PF has been EPA president in 2022 and is a co-editor of the German (DGPPN) schizophrenia treatment guidelines and a co-author of the WFSBP schizophrenia treatment guidelines; he is on the advisory boards and receives speaker fees from Janssen, Lundbeck, Otsuka, Servier and Richter.
: Data and samples used for these analyses were obtained from the PsyCourse Study, a longitudinal, multisite, observational transdiagnostic study that was conducted at in Germany and Austria within the frameworks of the Clinical Research Group 241 (KFO241 consortium; ) and the PsyCourse consortium (). The study design has been described in detail elsewhere (PMID: 30070057; ). The official period of data collection was from January 2012 through December 2019. The study protocol was approved by the respective ethics committee for each study center and was carried out following the rules of the Declaration of Helsinki. All study participants provided written informed consent.
